Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis : can we use them for clinical decision guidance?
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Tuberculosis
- Vol. 110, 44-51
Abstract
No abstract availableKeywords
Funding Information
- Centre for Toxicogenomics and Human Health (UID/BIM/00009/2013)
- GenomePT (POCI-01-0145-FEDER-022184)
This publication has 41 references indexed in Scilit:
- Incubation Time of Mycobacterial Cultures: How Long Is Long Enough To Issue a Final Negative Report to the Clinician?Journal of Clinical Microbiology, 2012
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutationJournal of Antimicrobial Chemotherapy, 2010
- A Balancing Act: Efflux/Influx in Mycobacterial Drug ResistanceAntimicrobial Agents and Chemotherapy, 2009
- Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2008
- Biological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in JapanJournal of Clinical Microbiology, 2008
- ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Activation of the Pro-drug Ethionamide Is Regulated in MycobacteriaJournal of Biological Chemistry, 2000
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994